Alphamab Oncology board resolves share repurchase up to HK$80 million
Board of Alphamab Oncology has resolved to repurchase shares with a maximum value of HK$80 million.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.